HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Some effects of the tumor promoter 12-0-tetradecanoylphorbol 13-acetate on cell interactions in vitro.

Abstract
Studies were made of the effects of the potent tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA), 4-O-methyl TPA (4-O-MeTPA), and 4 alpha phorbol 12,13-didecanoate (4 alpha PDD) on the aggregation of embryonic chick cells in gyratory shaker culture, a model system useful for the study of cell adhesion and cell interactions. TPA and, to a lesser extent, 4-O-MeTPA significantly reduced the neural retina aggregate size at concentrations as low as 10(-9) M and 10(-8) M, respectively. An inactive isomer, 4 alpha PDD, had no effect up to 10(-6) M. The reduction in aggregate size appeared related to promoter activity since dexamethasone, a steroid that inhibits tumor promotion by TPA, significantly reversed the inhibitory effect of TPA. None of the agents tested affected the sorting pattern in mixed neural retina and heart cultures. The results indicate that intercellular adhesion, as determined by extent of aggregation, is reduced in the presence of TPA. This inhibition is considered to be related to the tumor-promoting activity of TPA.
AuthorsD E Maslow, E G Mayhew, C E Wenner
JournalJournal of the National Cancer Institute (J Natl Cancer Inst) Vol. 69 Issue 3 Pg. 721-4 (Sep 1982) ISSN: 0027-8874 [Print] United States
PMID6955561 (Publication Type: Comparative Study, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Phorbols
  • Dexamethasone
  • Tetradecanoylphorbol Acetate
Topics
  • Animals
  • Cell Aggregation (drug effects)
  • Cell Differentiation (drug effects)
  • Cell Separation
  • Cells, Cultured
  • Chick Embryo
  • Dexamethasone (pharmacology)
  • Dose-Response Relationship, Drug
  • Embryo, Mammalian
  • Embryo, Nonmammalian
  • Phorbols (pharmacology)
  • Retina (cytology, drug effects)
  • Tetradecanoylphorbol Acetate (analogs & derivatives, antagonists & inhibitors, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: